A groundbreaking shift in Canadian drug policy has happened, as the government permit the availability of psilocybin hallucinogens for therapeutic purposes. Before this, these substances were severely restricted, but a increasing body of evidence suggests they potentially offer relief for emotional issues like anxiety. This development represents a